Regeneron Pharmaceuticals, Inc.
corporate_fare Company Profile
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 47 items for REGN at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Japan Approves Dupixent as First Targeted Treatment for Bullous Pemphigoid, Boosting Regeneron's Key Drug
- Pfizer's Mid-Stage Tilrekimig Data Poses Threat to Regeneron's Dupixent, Shares Dip
- Regeneron-Licensed Obesity Drug Olatorepatide Delivers Up to 19% Weight Loss in Positive Phase 3 China Trial
- Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment
- Regeneron Details Significant Legal Challenges and EYLEA Biosimilar Impact in Annual Report
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$14.34B
Net Income
$4.5B
Diluted EPS
$41.48
Op. Cash Flow
$4.98B
Free Cash Flow
$4.08B
Operating Income
$3.58B
Cash & Equivalents
$3.12B
Total Debt
$1.99B
Debt / Equity
0.06×
Net Margin
31.4%
Shares Outstanding
104.6M sh
Source: 10-K · filed 2026-02-04 · accession 0000872589-26-000008
show_chartPrice Chart
Loading chart...
feed REGN - Filings & News (Page 3)
REGN
Mar 24, 2026, 2:00 AM EDT
Price at Filing:
$736.53
Real-time Price:
$920.59
Change:
+$184.06 (+25%)
Market Cap:
$95.228B
REGN
Mar 11, 2026, 4:03 PM EDT
Price at Filing:
$774.66
Real-time Price:
$920.59
Change:
+$145.93 (+19%)
Market Cap:
$95.228B
REGN
Mar 09, 2026, 7:00 AM EDT
Price at Filing:
$741.98
Real-time Price:
$920.59
Change:
+$178.61 (+24%)
Market Cap:
$95.228B
REGN
Feb 27, 2026, 7:03 AM EST
Price at Filing:
$768.00
Real-time Price:
$920.59
Change:
+$152.59 (+20%)
Market Cap:
$95.228B
REGN
Feb 04, 2026, 9:08 AM EST
Price at Filing:
$763.00
Real-time Price:
$920.59
Change:
+$157.59 (+21%)
Market Cap:
$95.228B
REGN
Jan 30, 2026, 6:51 AM EST
Price at Filing:
$740.01
Real-time Price:
$920.59
Change:
+$180.58 (+24%)
Market Cap:
$95.228B
REGN
Jan 12, 2026, 6:48 AM EST
Price at Filing:
$796.55
Real-time Price:
$920.59
Change:
+$124.04 (+16%)
Market Cap:
$95.228B